A.
Bernard Ackerman, MD, is an exceptionally distinguished dermatologist and one
of the world's foremost authorities on the subject of skin cancer. In 1999, after
a long career in academic medicine, he founded and became director of the Ackerman
Academy of Dermatopathology in New York.
Largely
because of his leadership and high standards, Dr. Ackerman's institution quickly
became the world's largest training center in the field of dermatopathology. (Dermatopathology
is the study of the disease processes that affect the skin. It involves detailed
knowledge of the microscopic anatomy of the skin's structure in health and disease.)
Dr. Ackerman and his six associates examine more than 100,000 skin specimens and
do more than 4,000 consultations per year. Dr. Ackerman has published 625 research
papers and his list of honors and awards includes this year's Master Award, given
to one person a year by the American Academy of Dermatology.
What
makes this accomplished scientist particularly interesting is not just his distinguished
career in academic medicine but the fact that he challenges some of the dermatology
profession's most cherished dogmas. According to an article in the New York Times
(July 20, 2004), at age 67, Dr. Ackerman "continues to teach and write, and
also to ask for data and question his field's conventional wisdom."
"The
field is just replete with nonsense," he told the Times. For instance:
Dr. Ackerman
does not believe that the link between melanoma and sun exposure (a central dogma
of dermatology) has been proven. He himself is deeply tanned and unafraid to expose
his body to the sun.
He
does not believe that sunburns, even the painful or blistering kind sustained
early in life, necessarily lead to cancer. While some studies do show a small
association, he says, others show none. Even those studies that show some such
correlation "disagree on when the danger period for sunburns is supposed
to be," writes Gina Kolata, author of the New York Times article. Taken as
a whole, "the research is inconsistent and fails to make the case."
He
doesn't buy the argument that sunscreens protect against melanoma. He points to
a recent editorial in an orthodox journal, Archives of Dermatology, which also
concludes that there is scant evidence to support this crucial dogma (Bigby 2004).
Finally,
while the incidence of basal cell and squamous cell carcinoma have been shown
to be closely linked to lifetime sun exposure, Dr. Ackerman challenges the tenet
that the more intense a person's exposure to the sun, the greater their risk of
melanoma. He believes that the data for this also is not compelling. Although
we are told that the incidence of melanoma increases in populations that live
nearer the equator, the correlation is not that simple. Epidemiological data on
melanoma, says Dr. Ackerman, are imprecise and inaccurate. The data simply "cannot
demonstrate cause and effect."
Indeed,
a recent case-control study of 966 patients (Kennedy, 2003) studying the effect
of painful sunburns and lifetime sun exposure on the incidence of several types
of skin cancer concluded that lifetime sun exposure is predominantly linked to
an increased risk of squamous cell carcinoma and to a lesser degree with two common
types of basal cell carcinoma. By contrast, this study found that lifetime sun
exposure appeared to be associated with a lower risk of malignant melanoma.
Dr.
Ackerman advises people to stay out of the sun in order to avoid premature aging
of their skin. He also says that if you are very fair, you can prevent squamous
cell carcinoma, a less dangerous cancer, by avoiding sunlight. (Squamous cell
carcinomas, although they can be disfiguring, are rarely life-threatening.) But
don't make the mistake of thinking that by avoiding sunlight or using sunscreen
you will be protected against deadly melanoma. This, he says, is a myth.
Other
knowledgeable researchers agree that sunscreens fail to protect against melanoma.
Dr. William B. Grant, for example, who heads the Sunlight, Nutrition and Health
Research Center (SUNARC) in San Francisco, points out that sunscreens primarily
block the shorter wavelength ultraviolet (UV) radiation, whereas it is the longer
wavelength UV that poses the greater risk for melanoma.
Dr.
Grant feels that while there is some evidence pointing to a link between sunlight
and melanoma, it is not a simple cause and effect relationship. There are many
other factors that have to be taken into account. For example, Dr. Grant points
out that while it is true that melanoma rates increase with increasing latitude,
it is also true that even as far north as Canada, Denmark and the Netherlands,
occupational exposure to solar UV radiation is associated with a reduced risk
of melanoma. Conversely, for those of northern European ancestry living south
of their latitude of origin, such as in Australia, New Zealand and the US, melanoma
rates are much higher than they are in their countries of origin.
In
addition, Dr. Grant points out that there is substantial evidence that dietary
factors, particularly vitamin D, can have a significant effect on the risk of
developing melanoma. He points to the work of Millen and colleagues, of the National
Institutes of Health, showing that diets rich in vitamin D and carotenoids, and
low in alcohol, may be associated with a reduction in risk for melanoma (Millen,
2004). Therefore, Dr. Grant feels that diverse factors including diet, skin type,
the presence, number and type of moles, and ethnic, ancestral and geographic origin
also have a major influence on melanoma risk. To say that sunlight causes melanoma
is at best an oversimplification and at worst a distortion of the scientific evidence
(Grant, 2004).
A
Melanoma Epidemic'
Dr.
Ackerman is a questioning sort of person. He even debates whether the much-vaunted
"epidemic" of melanoma actually exists. The definition of melanoma,
he points out, has changed over the past few decades, leading doctors to diagnose,
remove and cure lesions that until recently would not have been called melanoma
at all.
"The
criteria today, clinically and histopathologically, are diametrically different
from those 30 years ago," he said. In medical school, he told the Times,
"we were taught that melanoma is a big, black, fungating tumor that kills.
Who would have believed then that you can recognize melanoma for what it is when
it is small and flat and the size of the fingernail on your pinky? You would have
said they were insane" (Kolata 2004).
As
noted, a central dogma of the dermatology profession is that sun exposure promotes
melanoma. The American Academy of Dermatology's website states that it is clear
that excessive sun exposure can promote the development of melanoma. But if this
is correct why do African-Americans and Asians develop melanoma precisely on those
parts of the skin that are not exposed to sunlight - the palms, soles, nails and
mucous membranes? Even among whites, the most common melanoma sites are the leg
(in women) and the trunk (in men). These are hardly the most sun-exposed body
parts. Why not on the face and arms, which are much more frequently exposed to
Old Sol?
Ackerman's
arguments (and he is by no means alone in feeling this way) leave conventional
dermatologists sputtering with frustration. One leader in the field told the New
York Times that "it was perverse of Dr. Ackerman to pick the data apart."
But is it perverse to question dogmatic beliefs? This official further claimed
that melanoma can occur in unexposed places because "sunlight suppresses
immune cells in the skin's surface that ordinarily hold cancer at bay." While
many would undoubtedly disagree with him, Dr. Ackerman does not accept this immune
surveillance' argument. He sees it as a tenuous theory manufactured in order to
support a dubious hypothesis.
This
insightful interview with Dr. Ackerman comes at a crucial moment in the history
of dermatology. In my opinion, the dermatologists have painted themselves into
a corner on the issue of sun exposure, sunscreens and melanoma. The best that
can be said is that they are trying to stem what they perceive to be a rising
tide of preventable melanoma cases with a public health campaign. But the science
behind this campaign is shaky, at best.
Some
leaders of the field, such as Dr. Ackerman, are now trying to help their profession
find its way back into the light. Although it is not mentioned in this interview,
the recent forced resignation of Michael Holick, MD, PhD, from his dermatology
professorship at Boston University has overshadowed this debate and moved it from
the back rooms of Academe squarely into the medico-political realm. As readers
of this newsletter may remember, Holick was asked to resign after he expressed
opinions that were essentially identical to those of Dr. Ackerman. But Dr. Holick
took his arguments directly to the laypeople in a popular book (The UV Advantage)
andunlike the retired Dr. Ackermanwas in a position that was vulnerable
to retaliation.
For
my previous articles on Dr. Holick click or go to any of the following:
I
believe the dermatology profession should reconsider its dogmatic positions on
the relationship of sunlight to melanoma. It should also reexamine its embrace
of the sunscreen industry, whose sales have grown from $18 million in 1972 to
almost a half billion dollars today. The supposedly protective effect of sunscreen
against the development of melanoma is a major reason for that boom. According
to medical writer Michael Castleman, writing in Mother Jones magazine:
"...[D]ermatologists
get much of their information from the SCF [Skin Cancer Foundation, ed.], and
the SCF, in turn, is heavily supported by the sunscreen industry. (A sunscreen
manufacturer even funded SCF's quarterly consumer publication, "Sun and Skin
News.") No wonder the foundation doesn't give much credence to the growing
number of studies showing that even so-called broad-spectrum sunscreen doesn't
prevent melanoma. Like the road-destroying trucks that guaranteed work for the
concrete company, rising melanoma rates scare people into using more sunscreen"
(Castleman 1998).
The
Skin Cancer Foundation has dozens of members of the sunscreen industry, such as
Pfizer, Johnson & Johnson and Procter & Gamble, on its "Corporate
Council." In return, the SCF awards its Seal of Recommendation to many
of these same companies' products. It is a cozy relationship indeed.
To
restore their collective good name, dermatologists need to come clean with the
public about what is scientifically proven and what is merely speculative about
the relationship between cancer and sunlight. In particular, truth-seekers in
the field need to band together and demand that B.U. reinstate Dr. Holick. Nothing
less will convince the public of the dermatology profession's intellectual honesty.
--Ralph
W. Moss, PhD
Note
from Chet: Be sure to sign up for Dr. Moss's excellent newsletter at his website.
References:
Bigby,
ME. The end of the sunscreen and melanoma controversy? Arch Dermatol. 2004 Jun;140(6):745-6.
Review.
Grant,
William B, PhD, personal communication July 28, 2004. Dr. Grant's Sunlight, Nutrition
and Health Research Center (SUNARC) www.sunarc.org
Kennedy
C, Bajdik C , Rein W, et al., The influence of painful sunburns and lifetime sun
exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi,
atypical nevi and skin cancer. J Investig Dermatol. 120, 1087-1093 (2003)
Kolata,
Gina. A Dermatologist Who's Not Afraid to Sit on the Beach. New York Times, July
20, 2004. Accessed July 24, 2004 from:
Millen,
AE, Tucker, MA, Hartge P, Halpern A, et al. Diet and melanoma in a case-control
study. Cancer Epidemiolo Biomarkers Prev. 2004 Jun;13(6):1042-51
Sunlight,
Nutrition and Health Research Center (SUNARC) www.sunarc.org
Click
Here to
share this page with your friends, website visitors, ezine readers, social followers
and other online contacts.
Disclaimer:
Throughout this website, statements are made pertaining to the properties and/or
functions of food and/or nutritional products. These statements have not been
evaluated by the Food and Drug Administration and these materials and products
are not intended to diagnose, treat, cure or prevent any disease.